These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21563652)

  • 21. The Ras inhibitor S-trans,trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance.
    Gana-Weisz M; Halaschek-Wiener J; Jansen B; Elad G; Haklai R; Kloog Y
    Clin Cancer Res; 2002 Feb; 8(2):555-65. PubMed ID: 11839677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
    Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
    Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat.
    Nakaji M; Yano Y; Ninomiya T; Seo Y; Hamano K; Yoon S; Kasuga M; Teramoto T; Hayashi Y; Yokozaki H
    Carcinogenesis; 2004 Mar; 25(3):389-97. PubMed ID: 14633663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells.
    Zvibel I; Bar-Zohar D; Kloog Y; Oren R; Reif S
    Dig Dis Sci; 2008 Apr; 53(4):1048-53. PubMed ID: 17934818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    Yue W; Wang J; Li Y; Fan P; Santen RJ
    Int J Cancer; 2005 Dec; 117(5):746-54. PubMed ID: 15957161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Ras antagonist blocks human melanoma growth.
    Jansen B; Schlagbauer-Wadl H; Kahr H; Heere-Ress E; Mayer BX; Eichler H; Pehamberger H; Gana-Weisz M; Ben-David E; Kloog Y; Wolff K
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14019-24. PubMed ID: 10570191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
    Santen RJ; Lynch AR; Neal LR; McPherson RA; Yue W
    Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Ras antagonist, farnesylthiosalicylic acid (FTS), decreases fibrosis and improves muscle strength in dy/dy mouse model of muscular dystrophy.
    Nevo Y; Aga-Mizrachi S; Elmakayes E; Yanay N; Ettinger K; Elbaz M; Brunschwig Z; Dadush O; Elad-Sfadia G; Haklai R; Kloog Y; Chapman J; Reif S
    PLoS One; 2011 Mar; 6(3):e18049. PubMed ID: 21445359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesol alleviates diethyl nitrosamine induced inflammation and protects experimental rat hepatocellular carcinoma.
    Balaraman G; Sundaram J; Mari A; Krishnan P; Salam S; Subramaniam N; Sirajduddin I; Thiruvengadam D
    Environ Toxicol; 2021 Dec; 36(12):2467-2474. PubMed ID: 34473392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis.
    Clarke HC; Kocher HM; Khwaja A; Kloog Y; Cook HT; Hendry BM
    J Am Soc Nephrol; 2003 Apr; 14(4):848-54. PubMed ID: 12660318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
    Katzav A; Kloog Y; Korczyn AD; Molina V; Blank M; Shoenfeld Y; Chapman J
    Immunobiology; 2003; 207(1):47-50. PubMed ID: 12638903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
    Yamamoto Y; Ono T; Dhar DK; Yamanoi A; Tachibana M; Tanaka T; Nagasue N
    J Gastroenterol Hepatol; 2008 Jun; 23(6):930-7. PubMed ID: 18565023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.
    Khan MS; Halagowder D; Devaraj SN
    Chem Biol Interact; 2011 Aug; 193(1):12-21. PubMed ID: 21554863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.